Hepatitis A (HAV) and hepatitis B (HBV) vaccination in patients with chronic liver disease is an accepted standard of care. We determined HAV and HBV vaccination rates in a tertiary care referral hepatology clinic and the impact of electronic health record (EHR)-based reminders on adherence to vaccination guidelines.We reviewed the records of 705 patients with chronic liver disease referred to our liver clinic in 2008 with at least two follow-up visits during the subsequent year. Demographics, referral source, etiology, and hepatitis serology were recorded. We determined whether eligible patients were offered vaccination and whether patients received vaccination. Barriers to vaccination were determined by a follow-up telephone interview.HAV...
BackgroundInfection with hepatitis A and hepatitis B virus can increase the risk of morbidity and mo...
Background and aims: Adherence to guidelines is associated with improved long-term outcomes in patie...
Background: Western Australian general practitioners may order Department of Health funded hepatitis...
Hepatitis A (HAV) and hepatitis B (HBV) vaccination in patients with chronic liver disease is an acc...
Background and aims. Despite effective vaccine available, hepatitis A remains a significant cause of...
Hepatitis A and B vaccine coverage is suboptimal in US adults, even among those at increased risk fo...
Introduction. The progression of chronic liver disease to cirrhosis involves both innate and adaptiv...
GoalsTo evaluate provider knowledge, attitudes and barriers to hepatitis B virus (HBV) care and mana...
<p>A) Hepatitis A vaccination. *Patients not eligible for HAV vaccination included those with positi...
Hepatitis A (HAV) and B (HBV) are highly transmittable, vaccine-preventable infections that can caus...
CC999999/Intramural CDC HHS/United StatesU18 PS005154/PS/NCHHSTP CDC HHS/United States2019-06-01T00:...
BACKGROUND AND AIM:Screenings for hepatitis B surface antigen (HBsAg) and antiviral prophylaxis are ...
BACKGROUND: Hepatitis A and B vaccines are effective in preventing superinfection and sequelae in pa...
Screenings for hepatitis B surface antigen (HBsAg) and antiviral prophylaxis are recommended for HBs...
The following groups are at increased risk of contracting or having severe outcomes from hepatitis A...
BackgroundInfection with hepatitis A and hepatitis B virus can increase the risk of morbidity and mo...
Background and aims: Adherence to guidelines is associated with improved long-term outcomes in patie...
Background: Western Australian general practitioners may order Department of Health funded hepatitis...
Hepatitis A (HAV) and hepatitis B (HBV) vaccination in patients with chronic liver disease is an acc...
Background and aims. Despite effective vaccine available, hepatitis A remains a significant cause of...
Hepatitis A and B vaccine coverage is suboptimal in US adults, even among those at increased risk fo...
Introduction. The progression of chronic liver disease to cirrhosis involves both innate and adaptiv...
GoalsTo evaluate provider knowledge, attitudes and barriers to hepatitis B virus (HBV) care and mana...
<p>A) Hepatitis A vaccination. *Patients not eligible for HAV vaccination included those with positi...
Hepatitis A (HAV) and B (HBV) are highly transmittable, vaccine-preventable infections that can caus...
CC999999/Intramural CDC HHS/United StatesU18 PS005154/PS/NCHHSTP CDC HHS/United States2019-06-01T00:...
BACKGROUND AND AIM:Screenings for hepatitis B surface antigen (HBsAg) and antiviral prophylaxis are ...
BACKGROUND: Hepatitis A and B vaccines are effective in preventing superinfection and sequelae in pa...
Screenings for hepatitis B surface antigen (HBsAg) and antiviral prophylaxis are recommended for HBs...
The following groups are at increased risk of contracting or having severe outcomes from hepatitis A...
BackgroundInfection with hepatitis A and hepatitis B virus can increase the risk of morbidity and mo...
Background and aims: Adherence to guidelines is associated with improved long-term outcomes in patie...
Background: Western Australian general practitioners may order Department of Health funded hepatitis...